person · Reporting owner

KOSECOFF JACQUELINE B

Disclosed activity across 8 companies

Tapewire entity: 42934
SEC CIK: 0001209524

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Alignment Healthcare, Inc.ALHC · Entity 4269	Director	March 13, 2026	March 17, 2026
GoodRx Holdings, Inc.GDRX · Entity 4838	Director	December 31, 2022	February 13, 2023
HOULIHAN LOKEY, INC.HLI · Entity 3553	Director	May 22, 2025	May 23, 2025
SEALED AIR CORP/DESEE · Entity 53140	Director	May 21, 2020	May 22, 2020
STERIS plcSTE · Entity 3228	Director	August 08, 2024	August 12, 2024
TRINET GROUP, INC.TNET · Entity 4202	Director	May 28, 2026	June 01, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Alignment Healthcare, Inc.

Report date March 13, 2026 · Filed March 17, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	303,963	Reported balance After 2026-03-13 transaction · row 1 1 source row Row 1 · 2026-03-13 · Grant · Acquired 13,096 · Balance 303,963 F1: Represents 13,096 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents 13,096 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

GoodRx Holdings, Inc.

Report date December 31, 2022 · Filed February 13, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	27,440	Reported balance After 2022-08-17 transaction · row 1 1 source row Row 1 · 2022-08-17 · Gift · Disposed 6,138 · Balance 27,440 F1: On August 17, 2022, the Reporting Person transferred 6,138 shares of Class A common stock to the Robert H. Brook and Jacqueline B. Kosecoff Family Trust, of which the Reporting Person and her spouse serve as trustees and are the sole beneficiaries.
Class A Common StockSEC Table I · non-derivative	IndirectBy Trust	6,138	Reported balance After 2022-08-17 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2022-08-17 · Gift · Acquired 6,138 · Balance 6,138 F1: On August 17, 2022, the Reporting Person transferred 6,138 shares of Class A common stock to the Robert H. Brook and Jacqueline B. Kosecoff Family Trust, of which the Reporting Person and her spouse serve as trustees and are the sole beneficiaries.

Filing footnotes · ownership attribution and instrument terms

F1: On August 17, 2022, the Reporting Person transferred 6,138 shares of Class A common stock to the Robert H. Brook and Jacqueline B. Kosecoff Family Trust, of which the Reporting Person and her spouse serve as trustees and are the sole beneficiaries.

HOULIHAN LOKEY, INC.

Report date May 22, 2025 · Filed May 23, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
CLASS A COMMON STOCKSEC Table I · non-derivative	Direct	15,316	Reported balance After 2025-05-22 transaction · row 1 1 source row Row 1 · 2025-05-22 · Grant · Acquired 563 · Balance 15,316

SEALED AIR CORP/DE

Report date May 21, 2020 · Filed May 22, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	4,167	Reported balance After 2020-05-21 transaction · row 1 1 source row Row 1 · 2020-05-21 · Grant · Acquired 4,167 · Balance 4,167 F1: Award made under the 2014 Omnibus Incentive Plan.
Common StockSEC Table I · non-derivative	IndirectBy Trust	40,937	Reported balance Holding disclosure · report date 2020-05-21 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 40,937 F2: Shares held indirectly in a trust for the benefit of Dr. Kosecoff and her husband.
Stock UnitsSEC Table II · derivative / convertible security	Direct	8,744	Reported balance Holding disclosure · report date 2020-05-21 · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · Balance 8,744 F3: 1-for-1 F4: The units are to be settled in shares of Common Stock (with certain exceptions specified in the Corporation's Deferred Compensation Plan for Directors) following the reporting person's retirement from the Board of Directors. F5: Reflects the addition of units converted from dividend equivalents.

Filing footnotes · ownership attribution and instrument terms

F1: Award made under the 2014 Omnibus Incentive Plan.

F2: Shares held indirectly in a trust for the benefit of Dr. Kosecoff and her husband.

F3: 1-for-1

F4: The units are to be settled in shares of Common Stock (with certain exceptions specified in the Corporation's Deferred Compensation Plan for Directors) following the reporting person's retirement from the Board of Directors.

F5: Reflects the addition of units converted from dividend equivalents.

STERIS plc

Report date August 08, 2024 · Filed August 12, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $239.68 · Expires 2034-08-08	Direct	1,388	Reported balance After 2024-08-08 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2024-08-08 · Grant · Acquired 1,388 · Balance 1,388 F1: These nonqualified stock options are fully vested and are exercisable immediately.
Career Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	6,546	Reported balance After 2024-08-08 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2024-08-08 · Grant · Acquired 494 · Balance 6,546 F2: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
Career Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	6,988	Reported balance After 2024-08-08 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2024-08-08 · Grant · Acquired 442 · Balance 6,988 F2: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $106,000 . F3: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Filing footnotes · ownership attribution and instrument terms

F1: These nonqualified stock options are fully vested and are exercisable immediately.

F2: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

F3: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

F4: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $106,000 .

TRINET GROUP, INC.

Report date May 28, 2026 · Filed June 01, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	4,735	Last balance in matching sequence After 2026-05-29 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2026-05-28 · Grant · Acquired 4,735 · Balance 7,384 F1: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the earlier of the 12-month anniversary of the date of grant and the trading day preceding the date of the Company's 2027 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events. F2: The total securities beneficially owned includes shares of unvested restricted stock units. Row 2 · 2026-05-29 · Gift · Disposed 2,649 · Balance 4,735 F3: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust. F2: The total securities beneficially owned includes shares of unvested restricted stock units.
Common StockSEC Table I · non-derivative	IndirectBy Trust	17,007	Reported balance After 2026-05-29 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2026-05-29 · Gift · Acquired 2,649 · Balance 17,007 F3: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust. F4: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the earlier of the 12-month anniversary of the date of grant and the trading day preceding the date of the Company's 2027 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events.

F2: The total securities beneficially owned includes shares of unvested restricted stock units.

F3: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust.

F4: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ATHENAHEALTH INC

Report date February 11, 2019 · Filed February 13, 2019

Section 16 reporting ended · disclosed 2019-02-13. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2019-02-11 transaction · row 1 1 source row Row 1 · 2019-02-11 · Disposition to issuer · Disposed 12,806 · Balance 0 F1: Pursuant to the terms of the Agreement and Plan of Merger, dated as of November 11, 2018, among athenahealth, Inc. (the "Company"), May Holding Corp., and May Merger Sub Inc. (the "Merger Agreement"), on February 11, 2019, each share of athenahealth common stock, par value $0.01 ("Common Stock") issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) and not otherwise excluded pursuant to the terms of the Merger Agreement, was converted into the right to receive $135.00 per share in cash (the "Merger Consideration"), subject to any required withholding taxes. F2: 1,931 of these securities represent shares of Common Stock underlying athenahealth restricted stock unit ("RSU") awards subject to time-based vesting. Pursuant to the Merger Agreement, on February 11, 2019, unvested RSUs outstanding immediately prior to the Effective Time were canceled and converted into the right to receive the Merger Consideration.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the terms of the Agreement and Plan of Merger, dated as of November 11, 2018, among athenahealth, Inc. (the "Company"), May Holding Corp., and May Merger Sub Inc. (the "Merger Agreement"), on February 11, 2019, each share of athenahealth common stock, par value $0.01 ("Common Stock") issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) and not otherwise excluded pursuant to the terms of the Merger Agreement, was converted into the right to receive $135.00 per share in cash (the "Merger Consideration"), subject to any required withholding taxes.

F2: 1,931 of these securities represent shares of Common Stock underlying athenahealth restricted stock unit ("RSU") awards subject to time-based vesting. Pursuant to the Merger Agreement, on February 11, 2019, unvested RSUs outstanding immediately prior to the Effective Time were canceled and converted into the right to receive the Merger Consideration.

STERIS plc

Report date March 28, 2019 · Filed March 28, 2019

Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Ordinary Shares, 10 pence par valueSEC Table I · non-derivative	IndirectSee Footnote Below	Reported balance After 2019-03-28 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2019-03-28 · Disposition to issuer · Disposed 42,830 · Balance 0 F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F2: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. 1,260 shares that had been directly held were transferred to the trust on November 23, 2018.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.08 · Expires 2019-07-31	Direct	Reported balance After 2019-03-28 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2019-03-28 · Disposition to issuer · Disposed 3,609 · Balance 0 F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,609 ordinary shares of STERIS for $28.08 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.34 · Expires 2020-08-04	Direct	Reported balance After 2019-03-28 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-03-28 · Disposition to issuer · Disposed 3,133 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.61 · Expires 2021-08-03	Direct	Reported balance After 2019-03-28 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2019-03-28 · Disposition to issuer · Disposed 3,121 · Balance 0 F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.36 · Expires 2022-08-03	Direct	Reported balance After 2019-03-28 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2019-03-28 · Disposition to issuer · Disposed 3,218 · Balance 0 F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.92 · Expires 2023-08-08	Direct	Reported balance After 2019-03-28 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2019-03-28 · Disposition to issuer · Disposed 4,657 · Balance 0 F7: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,657 ordinary shares of STERIS for $43.92 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.53 · Expires 2024-08-06	Direct	Reported balance After 2019-03-28 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2019-03-28 · Disposition to issuer · Disposed 4,584 · Balance 0 F8: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,584 ordinary shares of STERIS for $51.53 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $64.05 · Expires 2025-08-31	Direct	Reported balance After 2019-03-28 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2019-03-28 · Disposition to issuer · Disposed 4,110 · Balance 0 F9: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,110 ordinary shares of STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.40 · Expires 2026-08-10	Direct	Reported balance After 2019-03-28 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2019-03-28 · Disposition to issuer · Disposed 3,781 · Balance 0 F10: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.23 · Expires 2027-08-09	Direct	Reported balance After 2019-03-28 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2019-03-28 · Disposition to issuer · Disposed 927 · Balance 0 F11: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 927 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.74 · Expires 2028-08-09	Direct	Reported balance After 2019-03-28 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2019-03-28 · Disposition to issuer · Disposed 436 · Balance 0 F12: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Career Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2019-03-28 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2019-03-28 · Disposition to issuer · Disposed 3,184 · Balance 0 F13: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.

Filing footnotes · ownership attribution and instrument terms

F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.

F2: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. 1,260 shares that had been directly held were transferred to the trust on November 23, 2018.

F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,609 ordinary shares of STERIS for $28.08 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F7: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,657 ordinary shares of STERIS for $43.92 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F8: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,584 ordinary shares of STERIS for $51.53 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F9: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,110 ordinary shares of STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F10: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F11: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 927 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F12: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F13: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 29, 2026 Filed Jun 1, 2026 22:00 UTC	TRINET GROUP, INC. TNET · Entity 4202	GiftCommon Stock	2,649	$0.00	$0.00	Disclosure SEC source: 0001209524-26-000002 · wk-form4_1780351227.xml · nonDerivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 17,007 F3 · kind: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust. F4 · ownership.nature: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust. Read SEC document
May 29, 2026 Filed Jun 1, 2026 22:00 UTC	TRINET GROUP, INC. TNET · Entity 4202	GiftCommon Stock	2,649	$0.00	$0.00	Disclosure SEC source: 0001209524-26-000002 · wk-form4_1780351227.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,735 F3 · kind: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust. F2 · balance_after: The total securities beneficially owned includes shares of unvested restricted stock units. Read SEC document
May 28, 2026 Filed Jun 1, 2026 22:00 UTC	TRINET GROUP, INC. TNET · Entity 4202	GrantCommon Stock	4,735	$0.00	$0.00	Disclosure SEC source: 0001209524-26-000002 · wk-form4_1780351227.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,384 F1 · shares: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the earlier of the 12-month anniversary of the date of grant and the trading day preceding the date of the Company's 2027 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events. F2 · balance_after: The total securities beneficially owned includes shares of unvested restricted stock units. Read SEC document
March 13, 2026 Filed Mar 17, 2026 20:55 UTC	Alignment Healthcare, Inc. ALHC · Entity 4269	GrantCommon Stock	13,096	$0.00	$0.00	Disclosure SEC source: 0001628280-26-018847 · wk-form4_1773780923.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,963 F1 · shares: Represents 13,096 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. Read SEC document
May 23, 2025 Filed May 28, 2025 22:38 UTC	TRINET GROUP, INC. TNET · Entity 4202	GiftCommon Stock	2,000	$0.00	$0.00	Disclosure SEC source: 0000937098-25-000111 · wk-form4_1748471908.xml · nonDerivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 14,358 F3 · kind: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust. F4 · ownership.nature: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust. Read SEC document
May 23, 2025 Filed May 28, 2025 22:38 UTC	TRINET GROUP, INC. TNET · Entity 4202	GiftCommon Stock	2,000	$0.00	$0.00	Disclosure SEC source: 0000937098-25-000111 · wk-form4_1748471908.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,649 F3 · kind: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust. F2 · balance_after: The total securities beneficially owned includes shares of unvested restricted stock units. Read SEC document
May 23, 2025 Filed May 28, 2025 22:38 UTC	TRINET GROUP, INC. TNET · Entity 4202	GrantCommon Stock	2,649	$0.00	$0.00	Disclosure SEC source: 0000937098-25-000111 · wk-form4_1748471908.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,649 F1 · shares: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the earlier of the 12-month anniversary of the date of grant and the trading day preceding the date of the Company's 2026 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events. F2 · balance_after: The total securities beneficially owned includes shares of unvested restricted stock units. Read SEC document
May 22, 2025 Filed May 23, 2025 20:33 UTC	HOULIHAN LOKEY, INC. HLI · Entity 3553	GrantCLASS A COMMON STOCK	563	$0.00	$0.00	Disclosure SEC source: 0001302215-25-000062 · wk-form4_1748032403.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,316 Read SEC document
March 13, 2025 Filed Mar 17, 2025 22:10 UTC	Alignment Healthcare, Inc. ALHC · Entity 4269	GrantCommon Stock	12,258	$0.00	$0.00	Disclosure SEC source: 0001628280-25-013250 · wk-form4_1742249419.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,867 F1 · shares: Represents 12,258 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. Read SEC document
August 08, 2024 Filed Aug 12, 2024 20:35 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	442	$239.68	$105,938.56	Disclosure SEC source: 0001628280-24-036794 · wk-form4_1723494932.xml · derivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,988 Underlying: Ordinary Shares · 442 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $106,000 . F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 08, 2024 Filed Aug 12, 2024 20:35 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	494	$0.00	$0.00	Disclosure SEC source: 0001628280-24-036794 · wk-form4_1723494932.xml · derivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,546 Underlying: Ordinary Shares · 494 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 08, 2024 Filed Aug 12, 2024 20:35 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	1,388	$0.00 Strike: $239.68	$0.00	Disclosure SEC source: 0001628280-24-036794 · wk-form4_1723494932.xml · derivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,388 Underlying: Ordinary Shares · 1,388 shares Expires 2034-08-08 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
May 28, 2024 Filed May 29, 2024 22:36 UTC	TRINET GROUP, INC. TNET · Entity 4202	GiftCommon Stock	2,807	$0.00	$0.00	Disclosure SEC source: 0000937098-24-000119 · wk-form4_1717022175.xml · nonDerivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 12,358 F3 · kind: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust. F4 · ownership.nature: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust. Read SEC document
May 28, 2024 Filed May 29, 2024 22:36 UTC	TRINET GROUP, INC. TNET · Entity 4202	GiftCommon Stock	2,807	$0.00	$0.00	Disclosure SEC source: 0000937098-24-000119 · wk-form4_1717022175.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 F3 · kind: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust. F2 · balance_after: The total securities beneficially owned includes shares of unvested restricted stock units. Read SEC document
May 24, 2024 Filed May 29, 2024 22:36 UTC	TRINET GROUP, INC. TNET · Entity 4202	GrantCommon Stock	2,000	$0.00	$0.00	Disclosure SEC source: 0000937098-24-000119 · wk-form4_1717022175.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,807 F1 · shares: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the earlier of the 12-month anniversary of the date of grant and the trading day preceding the date of the Company's 2025 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events. F2 · balance_after: The total securities beneficially owned includes shares of unvested restricted stock units. Read SEC document
May 23, 2024 Filed May 24, 2024 20:59 UTC	HOULIHAN LOKEY, INC. HLI · Entity 3553	GrantCLASS A COMMON STOCK	739	$0.00	$0.00	Disclosure SEC source: 0001302215-24-000038 · wk-form4_1716584337.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,753 Read SEC document
May 13, 2024 Filed May 15, 2024 20:39 UTC	STERIS plc STE · Entity 3228	Exercise / conversionDirector Stock Option (right to buy) · Derivative	4,584	$0.00 Strike: $51.53	$0.00	Disclosure SEC source: 0001628280-24-023614 · wk-form4_1715805545.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,584 shares Expires 2024-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 4,584 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,584 ordinary shares for $51.53 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
May 13, 2024 Filed May 15, 2024 20:39 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	4,584	$231.53	$1,061,333.52	Disclosure SEC source: 0001628280-24-023614 · wk-form4_1715805545.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $231.3719 to $231.74 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document
May 13, 2024 Filed May 15, 2024 20:39 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	4,584	$51.53	$236,213.52	Disclosure SEC source: 0001628280-24-023614 · wk-form4_1715805545.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 13, 2024 Filed Mar 16, 2024 00:00 UTC	Alignment Healthcare, Inc. ALHC · Entity 4269	GrantCommon Stock	40,000	$0.00	$0.00	Disclosure SEC source: 0001209191-24-004879 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,609 F1 · kind: Represents 40,000 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares for three years (or, if earlier, until separation from service or a change of control of the Company). Read SEC document
August 31, 2023 Filed Sep 5, 2023 22:08 UTC	TRINET GROUP, INC. TNET · Entity 4202	Disposition to issuerCommon Stock	1,105	$107.00	$118,235.00	Disclosure SEC source: 0000937098-23-000181 · wk-form4_1693951713.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 9,554 F1 · shares: The share amount reported is based on an estimate of the number of shares accepted by the Issuer in the Issuer's fixed price tender offer, the results of which are reported in the Issuer's press release dated August 31, 2023. F1 · price: The share amount reported is based on an estimate of the number of shares accepted by the Issuer in the Issuer's fixed price tender offer, the results of which are reported in the Issuer's press release dated August 31, 2023. F2 · ownership.nature: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust. Read SEC document
August 31, 2023 Filed Sep 8, 2023 22:40 UTC Amendment	TRINET GROUP, INC. TNET · Entity 4202	Disposition to issuerCommon Stock	1,108	$107.00	$118,556.00	Disclosure SEC source: 0000937098-23-000192 · wk-form4a_1694212804.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 9,551 F1 · shares: This amended Form 4 is being filed to reflect the actual number of shares of Common Stock accepted by the Issuer in the Issuer's fixed price tender offer. The initial Form 4 (filed on September 5, 2023) that this filing amends was based on an estimate of the number of shares accepted by the Issuer in the Issuer's fixed price tender offer, the results of which are reported in the Issuer's press release dated August 31, 2023. F2 · ownership.nature: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust. Read SEC document
August 03, 2023 Filed Aug 7, 2023 20:35 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	364	$225.50	$82,082.00	Disclosure SEC source: 0001209191-23-044829 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,052 Underlying: Ordinary Shares · 364 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of $82,000 in fees. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 03, 2023 Filed Aug 7, 2023 20:35 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	525	$0.00	$0.00	Disclosure SEC source: 0001209191-23-044829 · doc4.xml · derivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,688 Underlying: Ordinary Shares · 525 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 03, 2023 Filed Aug 7, 2023 20:35 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	261	$76.72 Strike: $225.50	$20,023.92	Disclosure SEC source: 0001209191-23-044829 · doc4.xml · derivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,805 Underlying: Ordinary Shares · 261 shares Expires 2033-08-03 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $20,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
August 03, 2023 Filed Aug 7, 2023 20:35 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	1,544	$0.00 Strike: $225.50	$0.00	Disclosure SEC source: 0001209191-23-044829 · doc4.xml · derivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,544 Underlying: Ordinary Shares · 1,544 shares Expires 2033-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
May 31, 2023 Filed Jun 2, 2023 21:09 UTC	TRINET GROUP, INC. TNET · Entity 4202	GiftCommon Stock	2,099	$0.00	$0.00	Disclosure SEC source: 0000937098-23-000135 · wk-form4_1685740161.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 10,659 F1 · ownership.nature: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust. Read SEC document
May 31, 2023 Filed Jun 2, 2023 21:09 UTC	TRINET GROUP, INC. TNET · Entity 4202	GiftCommon Stock	2,099	$0.00	$0.00	Disclosure SEC source: 0000937098-23-000135 · wk-form4_1685740161.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,807 Read SEC document
May 24, 2023 Filed May 25, 2023 23:10 UTC	HOULIHAN LOKEY, INC. HLI · Entity 3553	GrantCLASS A COMMON STOCK	1,013	$0.00	$0.00	Disclosure SEC source: 0001302215-23-000053 · wf-form4_168505619799348.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,014 Read SEC document
May 15, 2023 Filed May 16, 2023 20:35 UTC	STERIS plc STE · Entity 3228	Exercise / conversionDirector Stock Option (right to buy) · Derivative	4,657	$0.00 Strike: $43.92	$0.00	Disclosure SEC source: 0001209191-23-029815 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,657 shares Expires 2023-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 4,657 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,657 ordinary shares for $43.92 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document
May 15, 2023 Filed May 16, 2023 20:35 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	4,657	$212.56	$989,891.92	Disclosure SEC source: 0001209191-23-029815 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $211.80 to $212.72 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document
May 15, 2023 Filed May 16, 2023 20:35 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	4,657	$43.92	$204,535.44	Disclosure SEC source: 0001209191-23-029815 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 23, 2023 Filed Mar 27, 2023 22:29 UTC	TRINET GROUP, INC. TNET · Entity 4202	GrantCommon Stock	2,807	$0.00	$0.00	Disclosure SEC source: 0000937098-23-000088 · wf-form4_167995616988808.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,906 F1 · shares: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the date of the Company's 2024 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events. Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:00 UTC	Alignment Healthcare, Inc. ALHC · Entity 4269	GrantCommon Stock	29,070	$0.00	$0.00	Disclosure SEC source: 0001209191-23-017845 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,609 F1 · kind: Represents 29,070 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares for three years (or, if earlier, until separation from service or a change of control of the Company). Read SEC document
August 17, 2022 Filed Feb 13, 2023 23:06 UTC	GoodRx Holdings, Inc. GDRX · Entity 4838	GiftClass A Common Stock	6,138	$0.00	$0.00	Disclosure SEC source: 0000899243-23-004839 · doc5.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 6,138 F1 · shares: On August 17, 2022, the Reporting Person transferred 6,138 shares of Class A common stock to the Robert H. Brook and Jacqueline B. Kosecoff Family Trust, of which the Reporting Person and her spouse serve as trustees and are the sole beneficiaries. F1 · balance_after: On August 17, 2022, the Reporting Person transferred 6,138 shares of Class A common stock to the Robert H. Brook and Jacqueline B. Kosecoff Family Trust, of which the Reporting Person and her spouse serve as trustees and are the sole beneficiaries. F1 · ownership.nature: On August 17, 2022, the Reporting Person transferred 6,138 shares of Class A common stock to the Robert H. Brook and Jacqueline B. Kosecoff Family Trust, of which the Reporting Person and her spouse serve as trustees and are the sole beneficiaries. Read SEC document
August 17, 2022 Filed Feb 13, 2023 23:06 UTC	GoodRx Holdings, Inc. GDRX · Entity 4838	GiftClass A Common Stock	6,138	$0.00	$0.00	Disclosure SEC source: 0000899243-23-004839 · doc5.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,440 F1 · shares: On August 17, 2022, the Reporting Person transferred 6,138 shares of Class A common stock to the Robert H. Brook and Jacqueline B. Kosecoff Family Trust, of which the Reporting Person and her spouse serve as trustees and are the sole beneficiaries. Read SEC document
August 03, 2022 Filed Aug 5, 2022 20:47 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	404	$203.00	$82,012.00	Disclosure SEC source: 0001209191-22-044582 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,163 Underlying: Ordinary Shares · 404 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of $82,000 in fees. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 03, 2022 Filed Aug 5, 2022 20:47 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	573	$0.00	$0.00	Disclosure SEC source: 0001209191-22-044582 · doc4.xml · derivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,759 Underlying: Ordinary Shares · 573 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 03, 2022 Filed Aug 5, 2022 20:47 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	321	$62.32 Strike: $203.00	$20,004.72	Disclosure SEC source: 0001209191-22-044582 · doc4.xml · derivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,190 Underlying: Ordinary Shares · 321 shares Expires 2032-08-03 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $20,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
August 03, 2022 Filed Aug 5, 2022 20:47 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	1,869	$0.00 Strike: $203.00	$0.00	Disclosure SEC source: 0001209191-22-044582 · doc4.xml · derivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,869 Underlying: Ordinary Shares · 1,869 shares Expires 2032-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
June 14, 2022 Filed Jun 16, 2022 20:10 UTC	GoodRx Holdings, Inc. GDRX · Entity 4838	GrantClass A Common Stock	27,440	$0.00	$0.00	Disclosure SEC source: 0000899243-22-022802 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,578 F1 · shares: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 14, 2022 and (ii) the date of the 2023 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. Read SEC document
June 02, 2022 Filed Dec 14, 2022 23:26 UTC	TRINET GROUP, INC. TNET · Entity 4202	GiftCommon Stock	2,576	$0.00	$0.00	Disclosure SEC source: 0000937098-22-000243 · wf-form4_167106039853237.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 8,560 F1 · ownership.nature: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust. Read SEC document
June 02, 2022 Filed Dec 14, 2022 23:26 UTC	TRINET GROUP, INC. TNET · Entity 4202	GiftCommon Stock	2,576	$0.00	$0.00	Disclosure SEC source: 0000937098-22-000243 · wf-form4_167106039853237.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,099 Read SEC document
May 27, 2022 Filed May 31, 2022 22:39 UTC	HOULIHAN LOKEY, INC. HLI · Entity 3553	GrantCLASS A COMMON STOCK	1,064	$0.00	$0.00	Disclosure SEC source: 0001302215-22-000057 · wf-form4_165403674212499.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,001 Read SEC document
March 24, 2022 Filed Mar 28, 2022 22:59 UTC	TRINET GROUP, INC. TNET · Entity 4202	GrantCommon Stock	2,099	$0.00	$0.00	Disclosure SEC source: 0000937098-22-000105 · wf-form4_164850834768183.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,675 F1 · shares: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the date of the Company's 2023 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events. Read SEC document
March 08, 2022 Filed Mar 10, 2022 23:27 UTC	Alignment Healthcare, Inc. ALHC · Entity 4269	GrantCommon Stock	16,556	$0.00	$0.00	Disclosure SEC source: 0001209191-22-018030 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,539 F1 · kind: Represents 16,556 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:38 UTC	STERIS plc STE · Entity 3228	Exercise / conversionDirector Stock Option (right to buy) · Derivative	3,218	$0.00 Strike: $32.36	$0.00	Disclosure SEC source: 0001209191-22-009475 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,218 shares Expires 2022-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:38 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	3,218	$235.20	$756,873.60	Disclosure SEC source: 0001209191-22-009475 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $235.1050 to $235.3850 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:38 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	3,218	$32.36	$104,134.48	Disclosure SEC source: 0001209191-22-009475 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 10, 2021 Filed Aug 12, 2021 20:36 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	468	$217.62	$101,846.16	Disclosure SEC source: 0001209191-21-051117 · doc4.xml · derivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,186 Underlying: Ordinary Shares · 468 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of $102,000 in fees. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.